Acquired chronic candidiasis treated with transfer factor.
A patient with acquired chronic oral and vaginal candidiasis resistant to topical and parenteral therapy was found to have impaired cell mediated immunity to Candida antigen and loss of skin test response to tuberculin (Mantoux). Treatment with Candida-active transfer factor produced clinical remission lasting 1 year and restitution of in vitro and in vivo immune parameters. Relapse occurred while receiving a second lot of transfer factor from the same donor. Subsequent treatment with levamisole was associated with onset of agranulocytosis.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D002180:Candidiasis, Oral / Q000276:immunology / Q000628:therapy*; D002181:Candidiasis, Vulvovaginal / Q000276:immunology / Q000628:therapy*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007978:Levamisole / Q000009:adverse effects; D012075:Remission, Spontaneous; D014165:Transfer Factor / Q000627:therapeutic use*
D014165:Transfer Factor; D007978:Levamisole